Publication:
Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication

dc.contributor.coauthorClarke, Callisia N.
dc.contributor.coauthorTsai, Susan
dc.contributor.coauthorEvans, Douglas B.
dc.contributor.kuauthorErkan, Murat Mert
dc.contributor.kuauthorAdsay, Nazmi Volkan
dc.contributor.kuauthorTaşkın, Orhun Çığ
dc.contributor.kuprofileFaculty Member
dc.contributor.researchcenterKoç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM)
dc.contributor.unitKoç University Hospital
dc.contributor.yokid214689
dc.contributor.yokid286248
dc.contributor.yokidN/A
dc.date.accessioned2024-11-09T13:07:59Z
dc.date.issued2020
dc.description.abstractSignificant improvements have taken place in our understanding of classification neuroendocrine neoplasms of the pancreas in the past decade. "These are now regarded in three entirely separate categories: (I) neuroendocrine tumors (PanNETs) are by definition well differentiated, the pancreatic counterpart of carcinoids; (II) neuroendocrine carcinomas, which are poorly differentiated (PDNEC), the pancreatic examples of small cell carcinomas or large cell neuroendocrine carcinomas; (III) other neoplasms that have neuroendocrine differentiation or a distinct neuroendocrine component. PanNETs are by far the most common. They are now regarded as malignancies (albeit often curable when low grade and low stage) with the exception of minute incidental proliferations (tumorlets, or dysplastic-like changes) seen in the setting of some syndromes like MEN. PanNETs are staged based on their size, and for small T1 tumors, watchful waiting is now being considered, although these tumors are also known to show about 10% metastatic rate and/or progression, creating concerns about this approach. PanNETs are graded into 3, based on the proliferative activity, mostly based on the Ki-67 index, and also partly mitotic activity, although the latter seldom if ever is the determinant of the final grade. Neuroendocrine neoplasms with well differentiated morphology but Ki-67 >20% are now regarded as Pa.nNFT Grade 3 (G3); they have been shown to have a prognosis significantly worse than lesser grade PanNETs but still incomparably better than frank PDNECs, the latter typically has Ki-67 >50% (often much higher) and require platinum-based chemotherapy. There are also cases that are ambiguous between PanNET-G3 and PDNEC, and very rarely transformation of the former to the latter appears to occur. For low grade (G 1/G2) PanNETs, more refined criteria to further prognosticate this group are needed. Morphologic variants being recognized may bring new perspectives to this group.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue3
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume11
dc.formatpdf
dc.identifier.doi10.21037/jgo.2020.03.07
dc.identifier.eissn2219-679X
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR02322
dc.identifier.issn2078-6891
dc.identifier.linkhttps://doi.org/10.21037/jgo.2020.03.07
dc.identifier.quartileQ4
dc.identifier.scopus2-s2.0-85090285071
dc.identifier.urihttps://hdl.handle.net/20.500.14288/2651
dc.identifier.wos544513800012
dc.keywordsPancreas
dc.keywordsNeuroendocrine neoplasm
dc.keywordsTumor
dc.keywordsCarcinoma
dc.keywordsPathology
dc.keywordsTerminology
dc.keywordsClassification
dc.keywordsPrognosis
dc.keywordsWHO 2019
dc.languageEnglish
dc.publisherAME Publishing Company
dc.relation.grantnoNA
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/8939
dc.sourceJournal of Gastrointestinal Oncology
dc.subjectMedicine
dc.subjectOncology
dc.subjectGastroenterology and hepatology
dc.titlePancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication
dc.typeReview
dspace.entity.typePublication
local.contributor.authorid0000-0002-2753-0234
local.contributor.authorid0000-0002-1308-3701
local.contributor.authoridN/A
local.contributor.kuauthorErkan, Murat Mert
local.contributor.kuauthorAdsay, Nazmi Volkan
local.contributor.kuauthorTaşkın, Orhun Çığ

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
8939.pdf
Size:
772.36 KB
Format:
Adobe Portable Document Format